Experimental Hematology

Journal

Publication Venue For

  • SOD2 deficiency in hematopoietic cells in mice results in reduced red blood cell deformability and increased heme degradation.  41:316-321. 2013
  • Combined BCR-ABL inhibition with lentiviral-delivered shRNA and dasatinib augments induction of apoptosis in Philadelphia-positive cells.  37:206-214. 2009
  • The host immune response is essential for the beneficial effect of adult stem cells after myocardial ischemia.  35:682-690. 2007
  • Canine hemangiosarcoma originates from hematopoietic precursors with potential for endothelial differentiation.  34:870-878. 2006
  • Contact with fibronectin enhances preservation of normal but not chronic myelogenous leukemia primitive hematopoietic progenitors.  30:324-332. 2002
  • Chronic myelogenous leukemia primitive hematopoietic progenitors demonstrate increased sensitivity to growth factor-induced proliferation and maturation.  28:1401-1412. 2000
  • Role of abnormal integrin-cytoskeletal interactions in impaired β1 integrin function in chronic myelogenous leukemia hematopoietic progenitors.  27:1384-1396. 1999
  • Co-culture of t cell depleted donor cells and leukemic blast cells in the presence of anti-ys antibody stimulates the in vitro proliferation of γδ t cells.  26:775. 1998
  • Knockout-transgenic mouse models of human hemoglobinopathies.  26:807. 1998
  • Use of dendritic cells and CD4 T-cells to expand yo Tcells for immunotherapy.  26:743. 1998
  • double-replacement gene targeting in mouse embryonic stem cells - creation of a mouse model for congenital polycythemia.  26:765. 1998
  • Abnormal pi integrin function in cml progenitors is related to enhanced receptor attachment to the cytoskeleton.  25:757. 1997
  • Defective progenitor/stroma interactions in the pathogenesis of chronic myeloid leukemia.  25:874. 1997
  • A clinically suitable ex vivo expansion culture system for LTC-IC and CFC using stroma-conditioned medium.  25:980-991. 1997
  • CML progenitor adhesion and adhesion-mediated proliferation inhibition is restored by tyrphostin ag957, a protein tyrosine kinase inhibitor with activity against the BCR-ABL kinase.  24:1131. 1996
  • Low incidence of epstein-barr virus associated b cell lymphoproliferative disorders following partially mismatched related donor bone marrow transplant.  24:1142. 1996
  • T lymphocyte reconstitution following preemptive donor leukocyte infusion therapy forpatientsathigh risk for relapse following T cell depleted bone marrow transplantation from a partially mismatched related donor.  24:1091. 1996
  • Characterization of acute bone marrow graft rejection in T cell-depleted, partially mismatched related donor bone marrow transplantation.  23:1595-1600. 1995
  • REGULATION OF EARLY HUMAN B-LYMPHOCYTE DIFFERENTIATION BY INTERLEUKIN-7.  22:717-717. 1994
  • The high affinity Fcγ receptor [CD64) induces phagocytosis in the absence of its cytoplasmic domain: The γ subunit of FcγRIIIA imparts phagocytic function to FcγRI.  22:599-606. 1994
  • Resistance of the stromal cells in murine long-term bone marrow cultures to damage by ionizing radiation.  14:1056-1062. 1986
  • Possibility of three distinct and separable components to fatal graft-vs-host reaction.  10:277-291. 1982
  • Graft-vs-leukemia and moderation of graft-vs-host reaction in transplantation therapy of viral leukemia.  9:754-765. 1981
  • Successful therapy of viral leukemia by transplantation of histocompatibility unmatched marrow.  6:273-282. 1978

    • International Standard Serial Number (issn)

  • 0301-472X

    • Electronic International Standard Serial Number (eissn)

  • 1873-2399